Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Buy
60
TRIP Quote, Financials, Valuation and Earnings
Last price:
$13.79
Seasonality move
:
13.46%
Day range:
$13.32 - $14.12
52-week range:
$12.93 - $28.76
Dividend yield:
0%
P/E ratio:
57.54x
P/S ratio:
1.12x
P/B ratio:
2.04x
Volume:
14.1M
Avg. volume:
2.4M
1-year change:
-34.8%
Market cap:
$1.9B
Revenue:
$1.8B
EPS (TTM):
$0.24
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.6B | $604M | $902M | $1.5B | $1.8B | |
| Revenue Growth (YoY) | -3.41% | -61.28% | 49.34% | 65.41% | 19.84% | |
| Cost of Revenues | $94M | $55M | $74M | $116M | $149M | |
| Gross Profit | $1.5B | $549M | $828M | $1.4B | $1.6B | |
| Gross Profit Margin | 93.97% | 90.89% | 91.8% | 92.23% | 91.67% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $859M | $489M | $636M | $956M | $1.1B | |
| Other Inc / (Exp) | -$4M | -$52M | -$10M | -$5M | -$26M | |
| Operating Expenses | $1.3B | $834M | $959M | $1.3B | $1.5B | |
| Operating Income | $188M | -$285M | -$131M | $101M | $148M | |
| Net Interest Expenses | -- | $32M | $44M | $29M | -- | |
| EBT. Incl. Unusual Items | $194M | -$369M | -$185M | $67M | $125M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $68M | -$80M | -$37M | $47M | $115M | |
| Net Income to Company | $126M | -$289M | -$148M | $20M | $10M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $126M | -$289M | -$148M | $20M | $10M | |
| Basic EPS (Cont. Ops) | $0.91 | -$2.14 | -$1.08 | $0.14 | $0.07 | |
| Diluted EPS (Cont. Ops) | $0.89 | -$2.14 | -$1.08 | $0.14 | $0.07 | |
| Weighted Average Basic Share | $139M | $135M | $137M | $140M | $139M | |
| Weighted Average Diluted Share | $141M | $135M | $137M | $146M | $145M | |
| EBITDA | $327M | -$209M | -$29M | $208M | $256M | |
| EBIT | $201M | -$334M | -$140M | $111M | $169M | |
| Revenue (Reported) | $1.6B | $604M | $902M | $1.5B | $1.8B | |
| Operating Income (Reported) | $188M | -$285M | -$131M | $101M | $148M | |
| Operating Income (Adjusted) | $201M | -$334M | -$140M | $111M | $169M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $151M | $303M | $459M | $533M | $532M | |
| Revenue Growth (YoY) | -64.72% | 100.66% | 51.49% | 16.12% | -0.19% | |
| Cost of Revenues | $13M | $23M | $32M | $43M | $47M | |
| Gross Profit | $138M | $280M | $427M | $490M | $485M | |
| Gross Profit Margin | 91.39% | 92.41% | 93.03% | 91.93% | 91.17% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $105M | $185M | $279M | $379M | $384M | |
| Other Inc / (Exp) | -$3M | -$1M | -$1M | -$20M | -$3M | |
| Operating Expenses | $181M | $264M | $357M | $408M | $416M | |
| Operating Income | -$43M | $16M | $70M | $82M | $69M | |
| Net Interest Expenses | $12M | $12M | $7M | -- | -- | |
| EBT. Incl. Unusual Items | -$58M | $3M | $62M | $64M | $66M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$10M | $2M | $37M | $37M | $27M | |
| Net Income to Company | -$48M | $1M | $25M | $27M | $39M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$48M | $1M | $25M | $27M | $39M | |
| Basic EPS (Cont. Ops) | -$0.36 | $0.01 | $0.18 | $0.20 | $0.28 | |
| Diluted EPS (Cont. Ops) | -$0.36 | $0.01 | $0.17 | $0.19 | $0.27 | |
| Weighted Average Basic Share | $134M | $138M | $140M | $138M | $139M | |
| Weighted Average Diluted Share | $134M | $144M | $146M | $143M | $144M | |
| EBITDA | -$15M | $43M | $96M | $96M | $100M | |
| EBIT | -$45M | $15M | $73M | $75M | $79M | |
| Revenue (Reported) | $151M | $303M | $459M | $533M | $532M | |
| Operating Income (Reported) | -$43M | $16M | $70M | $82M | $69M | |
| Operating Income (Adjusted) | -$45M | $15M | $73M | $75M | $79M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $823M | $777M | $1.4B | $1.8B | $1.8B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $63M | $67M | $105M | $144M | $164M | |
| Gross Profit | $760M | $710M | $1.3B | $1.6B | $1.7B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $565M | $576M | $877M | $1.3B | $1.1B | |
| Other Inc / (Exp) | -$54M | $1M | -$12M | -$23M | -$11M | |
| Operating Expenses | $928M | $906M | $1.2B | $1.5B | $1.5B | |
| Operating Income | -$168M | -$196M | $85M | $100M | $126M | |
| Net Interest Expenses | $18M | $48M | $38M | -- | -- | |
| EBT. Incl. Unusual Items | -$243M | -$243M | $35M | $77M | $120M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$42M | -$52M | $42M | $101M | $84M | |
| Net Income to Company | -$201M | -$191M | -$7M | -$24M | $36M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$201M | -$191M | -$7M | -$24M | $36M | |
| Basic EPS (Cont. Ops) | -$1.51 | -$1.41 | -$0.05 | -$0.17 | $0.25 | |
| Diluted EPS (Cont. Ops) | -$1.51 | -$1.41 | -$0.07 | -$0.18 | $0.24 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -$91M | -$79M | $179M | $208M | $254M | |
| EBIT | -$219M | -$195M | $80M | $121M | $166M | |
| Revenue (Reported) | $823M | $777M | $1.4B | $1.8B | $1.8B | |
| Operating Income (Reported) | -$168M | -$196M | $85M | $100M | $126M | |
| Operating Income (Adjusted) | -$219M | -$195M | $80M | $121M | $166M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $488M | $661M | $1.1B | $1.4B | $1.4B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $42M | $54M | $85M | $113M | $128M | |
| Gross Profit | $446M | $607M | $1.1B | $1.3B | $1.3B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $378M | $465M | $705M | $1B | $1B | |
| Other Inc / (Exp) | -$53M | -$1M | -$4M | -$22M | -$6M | |
| Operating Expenses | $638M | $710M | $940M | $1.2B | $1.2B | |
| Operating Income | -$192M | -$103M | $113M | $112M | $90M | |
| Net Interest Expenses | $19M | $35M | $27M | -- | -- | |
| EBT. Incl. Unusual Items | -$264M | -$139M | $82M | $93M | $88M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$47M | -$20M | $60M | $115M | $84M | |
| Net Income to Company | -$217M | -$119M | $22M | -$22M | $4M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$217M | -$119M | $22M | -$22M | $4M | |
| Basic EPS (Cont. Ops) | -$1.62 | -$0.87 | $0.16 | -$0.15 | $0.02 | |
| Diluted EPS (Cont. Ops) | -$1.62 | -$0.87 | $0.14 | -$0.16 | $0.01 | |
| Weighted Average Basic Share | $404M | $411M | $418.8M | $418.9M | $416.2M | |
| Weighted Average Diluted Share | $404M | $417M | $430.6M | $429.1M | $427.2M | |
| EBITDA | -$148M | -$19M | $189M | $189M | $187M | |
| EBIT | -$242M | -$104M | $116M | $126M | $123M | |
| Revenue (Reported) | $488M | $661M | $1.1B | $1.4B | $1.4B | |
| Operating Income (Reported) | -$192M | -$103M | $113M | $112M | $90M | |
| Operating Income (Adjusted) | -$242M | -$104M | $116M | $126M | $123M | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $319M | $418M | $723M | $1B | $1.1B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $176M | $70M | $105M | $173M | $177M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $27M | $22M | $26M | $44M | $38M | |
| Total Current Assets | $533M | $573M | $940M | $1.3B | $1.3B | |
| Property Plant And Equipment | $344M | $294M | $257M | $221M | $206M | |
| Long-Term Investments | $55M | $40M | $36M | $34M | $32M | |
| Goodwill | $840M | $862M | $843M | $822M | $829M | |
| Other Intangibles | $110M | $86M | $65M | $51M | $43M | |
| Other Long-Term Assets | $95M | $104M | $94M | $93M | $44M | |
| Total Assets | $2B | $2B | $2.3B | $2.6B | $2.5B | |
| Accounts Payable | $11M | $18M | $27M | $39M | $28M | |
| Accrued Expenses | $101M | $80M | $101M | $150M | $154M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $25M | $26M | $26M | $20M | $16M | |
| Other Current Liabilities | $63M | $53M | $51M | $54M | $66M | |
| Total Current Liabilities | $435M | $242M | $357M | $533M | $572M | |
| Long-Term Debt | -- | $491M | $833M | $836M | $839M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $823M | $1.1B | $1.5B | $1.7B | $1.7B | |
| Common Stock | -- | -- | -- | -- | -- | |
| Other Common Equity Adj | -$63M | -$34M | -$56M | -$82M | -$71M | |
| Common Equity | $1.2B | $886M | $789M | $861M | $871M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $1.2B | $886M | $789M | $861M | $871M | |
| Total Liabilities and Equity | $2B | $2B | $2.3B | $2.6B | $2.5B | |
| Cash and Short Terms | $319M | $418M | $723M | $1B | $1.1B | |
| Total Debt | -- | $491M | $833M | $836M | $839M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $446M | $682M | $1.1B | $1.1B | $1.1B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $80M | $151M | $150M | $214M | $220M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $26M | $28M | $38M | $43M | $62M | |
| Total Current Assets | $613M | $960M | $1.3B | $1.4B | $1.5B | |
| Property Plant And Equipment | $310M | $263M | $223M | $211M | $215M | |
| Long-Term Investments | $40M | $38M | $34M | $32M | $31M | |
| Goodwill | $843M | $846M | $803M | $817M | $834M | |
| Other Intangibles | $91M | $69M | $55M | $45M | $37M | |
| Other Long-Term Assets | $94M | $99M | $90M | $44M | $43M | |
| Total Assets | $2B | $2.3B | $2.6B | $2.6B | $2.7B | |
| Accounts Payable | $14M | $22M | $67M | $70M | $75M | |
| Accrued Expenses | $60M | $179M | $119M | $132M | $152M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | $5M | |
| Current Portion Of Capital Lease Obligations | $27M | -- | $21M | $18M | $13M | |
| Other Current Liabilities | $60M | -- | $64M | $80M | $62M | |
| Total Current Liabilities | $231M | $363M | $573M | $719M | $792M | |
| Long-Term Debt | $490M | $832M | $836M | $839M | $832M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1.1B | $1.5B | $1.8B | $1.8B | $1.8B | |
| Common Stock | -- | -- | -- | -- | -- | |
| Other Common Equity Adj | -$55M | -$51M | -$108M | -$89M | -$61M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $908M | $794M | $813M | $823M | $944M | |
| Total Liabilities and Equity | $2B | $2.3B | $2.6B | $2.6B | $2.7B | |
| Cash and Short Terms | $446M | $682M | $1.1B | $1.1B | $1.1B | |
| Total Debt | $490M | $832M | $836M | $839M | $837M | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $126M | -$289M | -$148M | $20M | $10M | |
| Depreciation & Amoritzation | $126M | $125M | $111M | $97M | $87M | |
| Stock-Based Compensation | $124M | $109M | $120M | $88M | $96M | |
| Change in Accounts Receivable | $23M | $92M | -$73M | -$87M | $6M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $424M | -$194M | $108M | $400M | $235M | |
| Capital Expenditures | $83M | $55M | $54M | $56M | $63M | |
| Cash Acquisitions | -$110M | -$4M | -- | -- | -- | |
| Cash From Investing | -$176M | -$56M | -$54M | -$52M | -$63M | |
| Dividends Paid (Ex Special Dividend) | -$488M | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $1.2B | $340M | -- | -- | |
| Long-Term Debt Repaid | -$5M | -$706M | -$6M | -$7M | -$7M | |
| Repurchase of Common Stock | -$60M | -$115M | -- | -- | -$100M | |
| Other Financing Activities | -$29M | -$38M | -$79M | -$20M | -$20M | |
| Cash From Financing | -$580M | $341M | $263M | -$27M | -$127M | |
| Beginning Cash (CF) | $655M | $319M | $418M | $723M | $1B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$332M | $91M | $317M | $321M | $45M | |
| Ending Cash (CF) | $319M | $418M | $723M | $1B | $1.1B | |
| Levered Free Cash Flow | $341M | -$249M | $54M | $344M | $172M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$48M | $1M | $25M | $27M | $39M | |
| Depreciation & Amoritzation | $30M | $28M | $23M | $21M | $21M | |
| Stock-Based Compensation | $29M | $28M | $22M | $24M | $31M | |
| Change in Accounts Receivable | -$17M | -$44M | $34M | $4M | $14M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$32M | -$63M | $60M | $14M | -$43M | |
| Capital Expenditures | $10M | $15M | $14M | $16M | $20M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$12M | -$15M | -$11M | -$16M | -$20M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $500M | -- | -- | -- | $493M | |
| Long-Term Debt Repaid | -$701M | -$2M | -$1M | -$2M | -$501M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$11M | -$10M | -$9M | -$2M | -$4M | |
| Cash From Financing | -$212M | -$12M | -$10M | -$4M | -$12M | |
| Beginning Cash (CF) | $698M | $775M | $1B | $1.1B | $1.2B | |
| Foreign Exchange Rate Adjustment | $4M | -$3M | -$18M | -$11M | $11M | |
| Additions / Reductions | -$256M | -$90M | $39M | -$6M | -$75M | |
| Ending Cash (CF) | $446M | $682M | $1.1B | $1.1B | $1.1B | |
| Levered Free Cash Flow | -$42M | -$78M | $46M | -$2M | -$63M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$201M | -$191M | -$7M | -$24M | $36M | |
| Depreciation & Amoritzation | $128M | $116M | $99M | $87M | $87M | |
| Stock-Based Compensation | $113M | $118M | $96M | $95M | $116M | |
| Change in Accounts Receivable | $119M | -$117M | -$23M | -$42M | -$34M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$120M | $29M | $505M | $214M | $128M | |
| Capital Expenditures | $69M | $49M | $55M | $62M | $67M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$82M | -$51M | -$50M | -$62M | -$67M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $1.2B | $340M | -- | -- | -- | |
| Long-Term Debt Repaid | -$705M | -$7M | -$6M | -$7M | -$507M | |
| Repurchase of Common Stock | -$175M | -- | -- | -- | -- | |
| Other Financing Activities | -$33M | -$80M | -$23M | -$19M | -$21M | |
| Cash From Financing | -$201M | $261M | -$29M | -$101M | -$85M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$403M | $239M | $426M | $51M | -$24M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$189M | -$20M | $450M | $152M | $61M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$217M | -$119M | $22M | -$22M | $4M | |
| Depreciation & Amoritzation | $94M | $85M | $73M | $63M | $63M | |
| Stock-Based Compensation | $80M | $89M | $65M | $72M | $92M | |
| Change in Accounts Receivable | $78M | -$131M | -$81M | -$36M | -$76M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$180M | $43M | $440M | $254M | $147M | |
| Capital Expenditures | $46M | $40M | $41M | $47M | $51M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$46M | -$41M | -$37M | -$47M | -$51M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $1.2B | $340M | -- | -- | $493M | |
| Long-Term Debt Repaid | -$704M | -$5M | -$5M | -$5M | -$505M | |
| Repurchase of Common Stock | -$115M | -- | -- | -$75M | -$25M | |
| Other Financing Activities | -$32M | -$74M | -$18M | -$17M | -$18M | |
| Cash From Financing | $349M | $269M | -$23M | -$97M | -$55M | |
| Beginning Cash (CF) | $1.8B | $1.9B | $2.5B | $3.3B | $3.4B | |
| Foreign Exchange Rate Adjustment | $4M | -$7M | -$37M | -$7M | $4M | |
| Additions / Reductions | $123M | $271M | $380M | $110M | $41M | |
| Ending Cash (CF) | $1.9B | $2.1B | $2.9B | $3.4B | $3.5B | |
| Levered Free Cash Flow | -$226M | $3M | $399M | $207M | $96M | |
Get TRIP Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
TRIP
Sector
P/E ratio
57.54x
16.53x
PEG ratio
--
0.01x
P/B ratio
2.04x
1.42x
Price / LTM sales
1.12x
0.94x
Growth Metrics
TRIP
Sector
Revenue growth
-0.19%
-0.19%
Earnings growth
42.11%
0.38%
Revenue (5-year growth)
2.06%
1.77%
Earnings forecast
$0.44
$0.14
Profitability
TRIP
Sector
Profitability FY 2023
$1.6B
$343.9M
Return on invested capital
2.11%
0.93%
Return on assets
1.34%
0.07%
Return on equity
4.17%
2.61%
Earnings Date
Last Earnings Date
Nov
6
Next Earnings Date
Feb
14
Estimated Next Earnings Date
Feb
5
Balance Sheet
TRIP
Sector
Total cash
$1.1B
$114.9M
Short term investments
--
$67.8M
Total assets
$2.5B
$1B
Long term debt
$837M
$54.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
